S10.4 · Food, Agriculture & Beverage
An established, feed-driven commodity protein source paired with a still-loss-making alternative-protein category chasing cost parity.
Global aquaculture production is worth roughly $280-300B (FAO State of World Fisheries and Aquaculture, 2024 edition), and farmed volume has exceeded wild catch since around 2022. Alternative protein — plant-based, fermentation-derived and cultivated — is a fraction of that at roughly $15-20B (Good Food Institute, 2025), and its growth has stalled since 2023 as investment capital pulled back sharply and plant-based retail sales plateaued. These are two businesses at opposite ends of maturity sharing a segment label: one an established commodity-priced protein source, the other a cost-down engineering race that has not yet proven it can hold a sustainable margin.
Aquaculture grows at a mid-single-digit rate. Production concentrates in China, Southeast Asia, Norway (salmon) and Chile. Outside salmon farming — where Mowi and SalMar hold dominant positions — the industry is fragmented, with numerous, regionally scattered operators. Alternative-protein R&D clusters in the US, EU, Israel and Singapore, and the competitive field there is fragmented among startups, most of them cash-constrained since the funding pullback that began in 2023.
Both halves buy from feed and genetics suppliers and sell into processing and retail, and there the resemblance ends. Aquaculture is commodity-priced and feed-cost-driven — structurally the same business as livestock production, with margins made or lost on the feed line. Alternative protein aspires to specification margin, differentiated on taste, texture and nutrition profile rather than sold as an undifferentiated commodity, but most producers are currently loss-making at scale, and the category has not yet demonstrated that its margin ambition survives the volumes needed to matter.
Feed and nutrition integration is about controlling cost volatility — feed being the largest controllable expense in both aquaculture and livestock production — and it defends existing margin rather than creating revenue. The incumbent food and ingredient companies backing alternative protein are doing something different: paying for optionality on a longer-term shift in protein demand, with no expectation of near-term earnings.
The most direct AI effect sits inside the aquaculture pens. Sensor and AI systems tracking feed waste and mortality in real time are collapsing the cost of monitoring the two variables that most directly determine a farm's profitability — how much feed is wasted and how many fish die before harvest. That is already the largest controllable cost line in aquaculture, and the monitoring is already deployed commercially, most visibly in salmon farming. In alternative protein, the relevant application is formulation: AI-assisted screening of ingredient and process combinations in search of better taste and cost profiles. Cost parity with conventional animal protein at meaningful scale remains 5-10 years out, if it is achieved at all, and the post-2023 funding contraction has slowed the pace of that work.